Search results
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
Benzinga via Yahoo Finance· 2 months agoBioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc...
Why Moderna, BioNTech SE, and Novavax Surged Today
Motley Fool· 9 months agoWhat happened Shares of vaccine developers Moderna (NASDAQ: MRNA), BioNTech SE (NASDAQ: BNTX), and Novavax (NASDAQ: NVAX) rallied hard on Monday, up...
The Zacks Analyst Blog Highlights Pfizer, BioNTech, Moderna and Morphic
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – August 25, 2022 – Zacks.com announces the list of stocks...
BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics
Zacks via Yahoo Finance· 1 year agoBioNTech (BNTX) signs a research collaboration agreement with Ryvu Therapeutics to develop small...
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
Reuters via Yahoo Finance· 2 years agoModerna is suing Pfizer and its German partner BioNTech for patent infringement in the development...
What's Going With BioNTech Stock On Monday?
Benzinga via Yahoo Finance· 2 weeks agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 4 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
Moderna (MRNA) Sues Pfizer and BioNTech Over COVID Jab
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) sues Pfizer and BioNTech, alleging that Comirnaty infringes on patents that Moderna...
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
Motley Fool· 8 months agoThe Food and Drug Administration (FDA) just approved the updated Omicron-adapted COVID-19 booster...
Why Shares of BioNTech Rose Friday
Motley Fool· 12 months agoShares of BioNTech (NASDAQ: BNTX) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive...
